P

Pioneer Clinical Research NY | New York, NY

Research site

(Unclaimed)

Location

37 E. 30th St Ground Floor, New York, New York, United States of America

Site insights

Top conditions

Top treatments

Mirikizumab

HZN-1116

ESK-001

RO7790121

Povorcitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 5 total trials

A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome

The purpose of this study is to measure the efficacy and safety of HZN-1116 in participants with Sjogren's syndrome (SS).

Enrolling

Sjogren's Syndrome

Drug: HZN-1116

Drug: Placebo

A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001 (ONWARD2)

The goal of this clinical trial is to learn if ESK-001 works to treat moderate to severe plaque psoriasis. The main questions it aims to answer are:*...

Enrolling

Plaque Psoriasis

Drug: ESK-001

Drug: Placebo

Locations recently updated

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

The main purpose of this study is to determine the safety and efficacy of eltrekibart and mirikizumab in adult participants with moderately to severe...

Enrolling

Ulcerative Colitis Chronic

Ulcerative Colitis

Drug: Placebo

Drug: Eltrekibart

A Study to Assess the Efficacy and Safety of RO7790121 for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (Ametrine-1)

This Phase III, multicenter, double-blind, placebo-controlled, treat-through study will evaluate the efficacy and safety of RO7790121 compared with p...

Enrolling

Moderately to Severely Active Ulcerative Colitis

Drug: Placebo

Drug: RO7790121